Rocket Lab has solidified its financial runway and customer relationships in a series of strategic moves, positioning the launch provider for its next major growth phase. The company concluded a substantial capital raise while locking in new launch contracts, underscoring its dual focus on near-term execution and long-term ambition.
The firm recently finalized its at-the-market (ATM) equity offering program, securing a significant war chest. Through direct share placements and collared forward transactions, Rocket Lab has raised or secured commitments for between approximately $948 million and $1.116 billion. The forward agreements extend until April 2028, providing guaranteed capital to fund operations and strategic initiatives.
A key target for this capital is already identified. Rocket Lab has received regulatory approval from the German government to acquire Munich-based laser communication specialist Mynaric, with the transaction expected to close this month. This technology is directly applicable to a major $1.3 billion satellite production contract with the Space Development Agency, highlighting the strategic nature of the purchase.
Commercial demand remains robust, evidenced by a new multi-launch agreement. Japanese satellite operator iQPS has booked three additional dedicated Electron launches from Rocket Lab’s New Zealand complex, scheduled from 2028 onward. This brings the total number of Electron missions for iQPS to 15, following seven successfully completed missions since 2023. At a list price of around $7.5 million per Electron launch, the lifetime value of this partnership exceeds $100 million. iQPS is building a constellation of radar satellites designed for all-weather, day-and-night Earth observation.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
This flurry of activity has not gone unnoticed by Wall Street. Analysts at Citizens JMP recently upgraded Rocket Lab’s stock from “Market Perform” to “Outperform,” assigning a price target of $85. The investment bank cited the company’s launch capacity, defense-related space projects, and a clearer path to higher-value space services as reasons for the bullish call.
The company’s backlog provides substantial visibility. At the end of the fourth quarter of 2025, Rocket Lab’s order book stood at approximately $1.85 billion. This figure includes the $1.3 billion SDA contract and a separate $190 million award for hypersonic testing. Management anticipates first-quarter 2026 revenue to land between $185 million and $200 million, with full-year 2026 revenue projected to reach about $880 million, up from $602 million in 2025.
All these efforts feed into the development of Neutron, Rocket Lab’s next-generation, partially reusable launch vehicle. Standing 43 meters tall, Neutron is designed to compete directly with SpaceX’s Falcon 9. Key components are now ready for final assembly, and the rocket remains on track for its inaugural flight in late 2026 or early 2027. The company will next report earnings on May 13, 2026, offering investors a fresh look at its progress.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from April 13 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 13.
Rocket Lab USA: Buy or sell? Read more here...
